14. June 2022
Read the Latest News
or Download our Publications.
7. June 2022
From CPUs to BPUs - a new generation of biocompatible semiconductors for rapid amplification-free genotyping being introduced at AGBT
San Diego, CA and Orlando, FL -- June 7, 2022 -- Today, at the prestigious Advances in Genome...
3. May 2022
Cardea Bio receives funding to develop electronic nose to rapidly diagnose infectious diseases via breath
Today, Cardea Bio, Inc. - the world's only mass producer of biocompatible semiconductors -...
27. April 2022
Securing international patents for mass-produced graphene biosensors
Today, Cardea Bio, Inc. - the world's first mass producer of graphene biosensors - shares their...
5. April 2022
Cardea Bio completes planned launch of CRISPR QC
San Diego, CA -- April 5, 2022 -- Today, Cardea Bio, Inc. - the world’s only mass producer of...
2. February 2022
Dr. Kiana Aran Receives NIH Funding to Help Set Quality Control Standards for CRISPR Therapies
Dr. Kiana Aran, Associate Professor of Medical Diagnostics and Therapeutics and head of the Aran...
10. January 2022
Cardea announces a collaboration agreement with Siemens Healthineers to assess feasibility of real-time applications
San Diego, CA -- January 10, 2022 -- Today, Cardea Bio, Inc. - the world’s only mass producer of...
9. December 2021
Cardea Bio accelerates commercial platform due to demand from market moving partners
To signal that Cardea Bio, Inc. is investing significantly into the commercialization efforts of...
22. June 2021
Cardea Bio Appoints Experienced Health Technology Executive, Dr. Kelly Huang, as Chief Operating Officer
Expanded Leadership Team Supports Continued Operational and Commercial Growth SAN DIEGO--(BUSINESS...
6. May 2021